0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

Vivos Inc

Healthcare US RDGL

0.185USD
-0.0149(7.45%)

Last update at 2024-05-16T16:48:00Z

Day Range

0.180.21
LowHigh

52 Week Range

0.040.12
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -2.47016M -2.52777M -0.95699M -1.61010M -7.70284M
Minority interest - - - - -
Net income -2.47016M -2.52777M -0.95699M -1.61010M -7.70284M
Selling general administrative 2.18M 2.22M 0.59M 1.27M 2.39M
Selling and marketing expenses - - - - -
Gross profit 0.00772M 0.00289M 0.00139M 0.00347M 0.00000M
Reconciled depreciation - - - - 0.00000M
Ebit -2.51775M -2.50180M -0.67252M -1.32998M -2.48964M
Ebitda -2.47016M -2.50239M -0.66952M -1.34872M -2.05330M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -2.51775M -2.50180M -0.67252M -1.32998M -2.47205M
Other operating expenses - - - - -
Interest expense 0.00000M 0.03M 0.29M 0.26M 5.65M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - - - - -
Net interest income 0.00000M -0.02538M -0.28747M -0.26137M -5.64955M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - 0.00000M
Total revenue 0.04M 0.01M 0.00700M 0.00950M 0.00000M
Total operating expenses 2.55M 2.52M 0.68M 1.34M 2.47M
Cost of revenue 0.03M 0.01M 0.00561M 0.00603M 0.00000M
Total other income expense net 0.05M -0.00059M 0.00300M -0.01874M 0.42M
Discontinued operations - - - - -
Net income from continuing ops -2.47016M -2.52777M -0.95699M -1.61010M -7.70284M
Net income applicable to common shares -2.47016M -2.52777M -0.95699M -1.61010M -7.70284M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1.74M 1.63M 0.94M 0.04M 0.02M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 0.08M 0.17M 0.91M 1.52M 0.96M
Total stockholder equity 1.66M 1.47M 0.03M -1.47969M -0.94217M
Deferred long term liab - - - - -
Other current liab - - 0.03M 0.03M 0.04M
Common stock 0.36M 0.34M 0.29M 0.18M 0.16M
Capital stock 0.37M 0.35M 0.30M 0.19M 1.31M
Retained earnings -79.55603M -77.08587M -74.55810M -73.60111M -71.99101M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 1.71M 1.61M 0.90M 0.02M 0.00549M
Cash and equivalents - - - - -
Total current liabilities 0.08M 0.17M 0.91M 1.52M 0.96M
Current deferred revenue - - - - -
Net debt - - - 0.77M 0.05M
Short term debt - - - - 0.05M
Short long term debt - - 0.34M 0.79M 0.05M
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - - -
Total current assets 1.74M 1.63M 0.94M 0.04M 0.02M
Long term investments - - - - -
Net tangible assets -7.97553M -8.16919M -9.71406M -11.69445M -11.69543M
Short term investments - - - - -
Net receivables 0.01M - - - -
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.08M 0.17M 0.36M 0.51M 0.80M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.00000M 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments - - - - 0.00000M
Change to liabilities 0.01M 0.03M -0.14994M -0.14287M -0.12952M
Total cashflows from investing activities - - - - -
Net borrowings - -0.14500M 0.10M 0.75M -0.04051M
Total cash from financing activities 1.22M 1.67M 1.76M 0.85M 0.70M
Change to operating activities 0.00250M -0.08588M -0.00716M 0.11M 0.68M
Net income -2.47016M -2.52777M -0.95699M -1.61010M -7.70284M
Change in cash 0.10M 0.70M 0.88M 0.01M -0.00282M
Begin period cash flow 1.61M 0.90M 0.02M 0.00549M 0.00832M
End period cash flow 1.71M 1.61M 0.90M 0.02M 0.00549M
Total cash from operating activities -1.12006M -0.96382M -0.87581M -0.83711M -0.70045M
Issuance of capital stock 1.22M 1.81M 1.66M 0.10M 0.74M
Depreciation - - - - 0.00000M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.01100M -0.01100M -0.01100M -0.01100M -
Sale purchase of stock - 0.00000M -0.06365M - -
Other cashflows from financing activities - 0.01M 0.01M 0.01M 0.01M
Change to netincome 1.35M 1.62M 0.18M 0.62M 5.66M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.00311M -0.05440M -0.15710M -0.03322M 0.55M
Stock based compensation - - 0.00218M 0.61M -
Other non cash items 1.35M 1.62M 0.24M 0.84M 2.23M
Free cash flow -1.12006M -0.96382M -0.87581M -0.83711M -0.70045M

Fundamentals

  • Previous Close 0.20
  • Market Cap26.09M
  • Volume912041
  • P/E Ratio-
  • Dividend Yield0.81%
  • Revenue TTM0.03M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00772M
  • Diluted EPS TTM-

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RDGL
Vivos Inc		 -0.0149 7.45% 0.18 - - 1125.87 20.10 1066.86 -11.0577
ABT
Abbott Laboratories		 0.46 0.44% 105.05 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 2.14 0.64% 334.13 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 0.43 0.51% 85.15 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.185 0.25% 74.27 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Vivos Inc

719 Jadwin Avenue, Richland, WA, United States, 99352

Key Executives

Name Title Year Born
Dr. Michael K. Korenko Ph.D. CEO, Pres & Director 1946
Dr. Carlton M. Cadwell D.D.S. Independent Chairman & Sec. 1945
Mr. Michael H. Pollack CPA, CPA Chief Financial Officer 1966
Dr. David J. Swanberg M.S., P.E. Chief Technical Mang. 1957
Dr. Nigel R. Stevenson B.Sc., Ph.D. Chief Science Officer NA
Dr. Fu-Min Su Chief Radio Chemist & Radiation Safety Officer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).